Hypercalcemia in Pulmonary TB - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Hypercalcemia in Pulmonary TB

Description:

The prevalence of hypercalcaemia in pulmonary and miliary tuberculosis--a longitudinal study. ... with pulmonary (n = 32) or miliary (n = 2) tuberculosis. ... – PowerPoint PPT presentation

Number of Views:107
Avg rating:3.0/5.0
Slides: 23
Provided by: CCW
Category:

less

Transcript and Presenter's Notes

Title: Hypercalcemia in Pulmonary TB


1
Hypercalcemia in Pulmonary TB
  • Chou Chien-Wen M.D.
  • Endocrine and Metabolism Section
  • Chi-Mei Medical Center
  • 8 Aug 2003

2
Case Report
  • Name ?x?
  • Sex Male
  • Age 87y/o
  • Admission Date 92/6/20-92/7/3
  • PI intermittent conscious disturbance
    with irrelevant speech, poor appetite,
    general malaise and weakness for 1-2 days
  • PH COPD BPH with TURP in 90-8

3
Laboratory Datas (1)
  • WBC 11700, HB 14.2, Pl 27 x 103
  • U/A WBC 8-10/HPF
  • BUN 38.6, Cr 3.01, Glu 91.5,
  • Na 138, K 3.78, Ca 12.88, P 3.1,
  • Alb 3.2, Alk.p 225, CRP 141
  • 24 hours urine Ca 425 mg, P 622 mg

4
Laboratory Datas (2)
  • CXR bronchiectasis superimposed
    infection over both lungs,
    emphysematous change of both lungs
  • Sputum culture K-P.
  • B/C no growth
  • U/C Pseudomonas Aeruginosa gt10000
  • T4 6.52, TSH 2.03, CEA 6.2, PSA 4.57, i-PTH 6.8
    pg/ml (normal 10-65)
  • Skull X ray small geographic lucencies at right
    frontal region
  • Bence-Jones protein negative

5
(No Transcript)
6
Laboratory Datas (3)
  • Sputum cytology negative
  • 92/6/22 Sputum smear Acid-fast stain
  • 92/6/25 Vit D1,25-OH 136 pg/ml
    (normal 15.9-55.6)
  • 92/6/26 Serum Ca 11.3
  • 92/6/30 Serum Ca 9.4, BUN 20.8, Cr 1.97
  • 92/6/30 Sputum smear Acid-fast stain negative

7
Treatment
  • Normal saline iv 80 cc/h
  • Bonefos 300 mg in 500 cc N/S iv 6 h for 2 days
  • Haldol 1 amp stat
  • 92/6/20 Cefazolin 1 gm iv q8h, GM 80 mg iv qd
  • 92/6/23 Rifater 5 qd, EMB 2 qd, vit B6 1 qd
    till discharge

8
Hypercalcaemia and hypokalaemia in tuberculosis
  • In two patients with extensive pulmonary
    tuberculosis who developed hypercalcaemia and
    hypokalaemia
  • the hypercalcaemia appeared related to the use of
    small doses of vitamin D, which suggested
    patients with tuberculosis were hypersensitive to
    vitamin D.
  • The hypercalcaemia was quickly suppressed with
    steroids.
  • The hypokalaemia was associated with increased
    renal excretion of potassium, and was probably
    due to distal tubular damage from hypercalcaemia.

Bradley GW. Thorax. 33(4)464-7, 1978 Aug.
9
Hypercalcemia in active pulmonary tuberculosis
  • 79 consecutive patients with active pulmonary
    tuberculosis and a control group of 79 patients
    with COPD
  • 22 patients developed hypercalcemia (serum
    calcium gt 10.5 mg/dl) within 4 to 16 weeks after
    initiation of chemotherapy for tuberculosis.
  • The duration of hypercalcemia ranged from 1 to 7
    months, and remission occurred spontaneously in
    all patients.
  • The mean daily vitamin D supplement was greater
    in hypercalcemic patients than in the
    normocalcemic group.
  • There was a positive correlation between daily
    vitamin D supplement and degree and duration of
    hypercalcemia.
  • Mean serum calcium in patients with tuberculosis
    was higher than in patients with chronic
    obstructive pulmonary disease supplemented with
    the same dose of vitamin D.
  • Hypercalcemia appears to be related to the
    activity of pulmonary tuberculosis and the intake
    of vitamin D the exact mechanism, however,
    remains unknown.

Abbasi AA. Annals of Internal Medicine.
90(3)324-8, 1979 Mar.
10
Evidence for abnormal regulation of circulating 1
alpha, 25-dihydroxyvitamin D in patients with
pulmonary tuberculosis and normal calcium
metabolism
  • vitamin D, 100,000 units a day for 4 days, were
    compared in 25 normal subjects and 11 patients
    with active pulmonary tuberculosis who were
    normocalcemic
  • Whereas vitamin D increased mean serum 25-OHD
    from 20 /- 2 (/- SE) to 40 /- 5 ng/ml (P less
    than 0.001) and did not change mean serum 1
    alpha, 25(OH)2D in the normals (33 /- 2 vs. 31
    /- 2 pg/ml), it increased mean serum 25-OHD from
    21 /- 4 to 55 /- 13 ng/ml (P less than 0.05)
    and mean serum 1 alpha, 25(OH)2D from 28 /- 2 to
    35 /- 3 pg/ml (P less than 0.05) in the
    patients.
  • Serum calcium was normal and remained within the
    normal range in all subjects and patients.
  • significant abnormality in the regulation of
    circulating 1 alpha, 25(OH)2D in normocalcemic
    patients with pulmonary tuberculosis.

Epstein S. Calcified Tissue International.
36(5)541-4, 1984 Sep
11
Hypercalcemia associated with increased
circulating 1,25 dihydroxyvitamin D in a patient
with pulmonary tuberculosis.
  • a 53-year-old man with far-advanced pulmonary
    tuberculosis who developed transient increases in
    circulating 1,25 dihydroxyvitamin D (1,25(OH)2D)
    and hypercalcemia while on antituberculous
    treatment.
  • Serum 25-hydroxyvitamin D (25OHD) was suppressed
    during the abnormal elevation of serum
    1,25(OH)2D.
  • It is concluded that tuberculosis is a chronic
    granulomatous disease in which hypercalcemia may
    result from abnormal metabolism of vitamin D.

Bell NH. Calcified Tissue International.
37(6)588-91, 1985 Dec.
12
Are tuberculous patients at a great risk from
hypercalcemia?.
  • The risk of tuberculous was investigated in 33
    patients aged 19 to 80.
  • 22 of the 33 received no vitamin D supplements.
  • After 17 to 34 days of chemotherapy serum calcium
    corrected for albumin and 1,25(OH)2D levels were
    lower without change in serum D-binding protein.
  • In 11 patients 25(OH)D, 50 micrograms/day, was
    given orally for two months. 25(OH)D given three
    days before chemotherapy in five patients induced
    an increase of levels of 1,25(OH)2D which was
    greater than in 10 control patients with similar
    serum levels of 25(OH)D.
  • When chemotherapy was added to 25(OH)D, the five
    patients showed high normal 1,25(OH)2D levels.
  • The last six patients received 25(OH)D together
    with or after starting chemotherapy.
  • None of the 33 patients developed hypercalcemia,
    even when supplemented with 25(OH)D for two
    months.
  • It appears that hypercalcemia is uncommon in
    tuberculosis.

Fuss M. Quarterly Journal of Medicine.
69(259)869-78, 1988 Nov.
13
Hypercalcemia in pulmonary tuberculosis
  • The incidence of hypercalcemia among unselected
    patients with active pulmonary tuberculosis was
    investigated, retrospectively, during a ten-year
    period.
  • Among 67 patients, the mean serum calcium
    concentration on admission was significantly
    raised compared to healthy controls (2.51 /-
    0.16 (SD) vs 2.43 /- 0.07 mmol/l p less than
    0.001) and 25 of the patients had hypercalcemia.
  • After one year of successful tuberculostatic
    treatment the serum calcium values had normalized

Lind L. Upsala Journal of Medical Sciences.
95(2)157-60, 1990
14
Hypercalcemia in active pulmonary tuberculosis
and its occurrence in relation to the
radiographic extent of disease
  • The prevalence of hypercalcemia in tuberculosis
    in Hong Kong and its occurrence in relation to
    the radiographic extent of disease were studied
    in 57 patients with sputum smear (n 44) and/or
    culture positive (n 13) pulmonary tuberculosis
    and in five patients with military tuberculosis
    prior to treatment.
  • Only one (1.6) patient had a corrected plasma
    calcium level above the reference range for our
    laboratory.
  • There was a positive relationship between the
    corrected plasma calcium levels and the
    radiographic extent of disease (r 0.37), p lt
    0.01).
  • a low prevalence of "absolute" hypercalcemia in
    Hong Kong could be related to the low dietary
    calcium intake in these subjects.

Chan TY Southeast Asian Journal of Tropical
Medicine Public Health. 23(4)702-4, 1992 Dec.
15
Ketoconazole decreases the serum ionized calcium
and 1,25-dihydroxyvitamin D levels in
tuberculosis-associated hypercalcemia
  • Two boys (aged 10.5 years and 14.7 years) with
    active tuberculosis and hypercalcemia.
  • At admission, serum 1,25-dihydroxyvitamin D
    levels were elevated. Oral ketoconazole
    administration (3.0 mg/kg every 8 hours)
    decreased 1,25-dihydroxyvitamin D levels within
    the first week of therapy (from 208.8 to 57.6
    pmol/L 72.4 in one boy and from 321.6 to 115.2
    pmol/L 64.2 in the other).
  • coincident normalization of serum ionized calcium
    concentration (from 1.45 to 1.24 mmol/L 13.0 in
    one boy and from 1.55 to 1.26 mmol/L 17.0 in the
    other).
  • CONCLUSIONS--Abnormal elevated levels of
    1,25-dihydroxyvitamin D caused hypercalcemia in
    our patients ketoconazole administration may be
    effective in the treatment of hypercalcemia in
    patients with tuberculosis, which decreases
    1,25-dihydroxyvitamin D synthesis

Saggese G. American Journal of Diseases of
Children. 147(3)270-3, 1993 Mar
16
The prevalence of hypercalcaemia in pulmonary and
miliary tuberculosis--a longitudinal study.
  • We studied the prevalence of hypercalcaemia in 34
    Chinese patients with pulmonary (n 32) or
    miliary (n 2) tuberculosis.
  • None of these subjects were given vitamin D or
    calcium supplements. .
  • During the 6-month study period, two patients
    (6) developed hypercalcaemia (plasma calcium
    greater than 2.51 mmol/l), as compared to figures
    of 16 to 28 in the United States and India.
  • By correcting the plasma calcium to a normal
    albumin, five (15) of our patients were
    hypercalcaemic, as compared to a figure of 48 in
    Greece.
  • Apart from variations in methodology,
    discrepancies in the reported prevalence of
    hypercalcaemia in tuberculosis may be due to
    differences in sun exposure, and vitamin D and
    calcium intake.

Chan TY. Singapore Medical Journal. 35(6)613-5,
1994 Dec
17
Hypercalcemic crisis in a patient with pulmonary
tuberculosis
  • Hypercalcemia occurs in 16 to 28 of patients
    with pulmonary tuberculosis.
  • Rarely, however, does the calcium rise to a level
    that requires emergency management.
  • In this report, a 49-year-old woman undergoing
    treatment for pulmonary tuberculosis presented
    with vomiting and weakness secondary to severe
    hypercalcemia. .
  • Physicians must maintain a high index of
    suspicion since prompt recognition and therapy
    will ensure a successful outcome.

Pruitt B. Journal - Oklahoma State Medical
Association. 88(12)518-20, 1995 Dec
18
Hypercalcemia and pulmonary tuberculosis in east
Tennessee
  • In a study of 83 patients with active pulmonary
    tuberculosis who were treated in East Tennessee,
    only three developed hypercalcemia.
  • The incidence of hypercalcemia in East Tennessee
    is markedly lower than that quoted in earlier
    studies performed in the United States.
  • The explanation for the infrequent occurrence of
    elevated serum calcium in our population is
    probably multifactorial, but does not appear to
    be related to the selection of antituberculous
    agents.

Hourany J. Tennessee Medicine. 90(12)493-5, 1997
Dec
19
Hypercalcemia, inappropriate calcitriol levels,
and tuberculosis on hemodialysis.
  • a female patient undergoing hemodialysis who
    developed tuberculosis, hypercalcemia, and
    inappropriately elevated calcitriol levels.
  • These findings suggest ectopic production of
    calcitriol by tuberculous granulomas.
  • Successful treatment of tuberculosis led to a
    substantial decrease in the levels of calcium and
    calcitriol

Peces R. Scandinavian Journal of Urology
Nephrology. 34(4)287-8, 2000 Aug
20
Hypercalcaemia in Greek patients with
tuberculosis before the initiation of
anti-tuberculosis treatment
  • We prospectively evaluated all patients with
    newly-diagnosed TB presenting, either as
    inpatients or as outpatients, to our hospital,
    during a 3-year period.
  • We evaluated 88 patients with TB (50 males and 38
    females), aged between 23 and 89 years (mean
    age/-SD 46.4/-19 years), and 65 age- and
    sex-matched controls with chronic obstructive
    pulmonary disease (36 males and 29 females), aged
    between 28 and 88 years (mean age/-SD 47.2/-18
    years).
  • Among TB patients, 56 had pulmonary TB, 20 had
    pleural TB without evidence of pulmonary
    parenchyma involvement, eight had pulmonary and
    pleural TB, and four had disseminated disease.

Roussos A. Respiratory Medicine. 95(3)187-90,
2001 Mar
21
Hypercalcaemia in Greek patients with
tuberculosis before the initiation of
anti-tuberculosis treatment
  • The mean (/-SD) albumin-adjusted serum calcium
    concentration and the mean ionized calcium
    concentration were significantly higher in the TB
    group (2.49/-0.21 mmol l(-1) and 1.27/-0.02
    mmol l(-1) respectively) than in the control
    group (2.36/-0.11 mmol l(-1) and 1.19/-0.02
    mmol l(-1), Plt0.05).
  • In the TB group no correlation between type of
    disease and albumin-adjusted or ionized calcium
    concentration was seen.
  • Hypercalcaemia was detected in 22 patients with
    TB (25) but only three showed symptoms
    associated with it.
  • We conclude that, although hypercalcaemia is a
    common laboratory finding among Greek patients
    with TB before anti-TB chemotherapy, it is
    usually asymtomatic.

Roussos A. Respiratory Medicine. 95(3)187-90,
2001 Mar
22
Sarcoidosis and other granulomatous diseases
  • Unregulated synthesis of 1,25(OH)2D3, found even
    in an anephric patient
  • Isolated sarcoid macrophages express the gene
    encoding the identical 25(OH)d 1 alfa-hydroxylase
  • Unusual sensitivity to b\vitamin D and become
    hypercalcemic in response to ultraviolet
    radiation or oral vitamin D intake
  • Also associated with other granulomatous
    diseases, such as tuberculosis, fungal
    infections. and berylliosis, Wegeners
    granulomatosis, AIDS-related Pneumocystitis
    carinii and extensive granulomatous foreign body
    reactios

Williams Textbook of Endocrinology, Tenth Edition
Write a Comment
User Comments (0)
About PowerShow.com